U.S. Markets close in 2 hrs 33 mins

Johnson & Johnson Receives Offer to Divest Sterilization Business

Sarah Collins
Johnson & Johnson Receives Offer to Divest Sterilization Business

On June 6, Johnson & Johnson (JNJ) announced it had received a $2.8 billion offer from Fortive (FTV) to sell its ASP (Advanced Sterilization Products) business, part of its subsidiary, Ethicon. Ethicon’s ASP business, a market leader in infection prevention solutions, generated sales of $775 million in fiscal 2017. Johnson & Johnson has 120 days to decide on the offer.